EA200801408A1 - Способы и композиции, применяемые при лечении расстройств желудочно-кишечного тракта - Google Patents
Способы и композиции, применяемые при лечении расстройств желудочно-кишечного трактаInfo
- Publication number
- EA200801408A1 EA200801408A1 EA200801408A EA200801408A EA200801408A1 EA 200801408 A1 EA200801408 A1 EA 200801408A1 EA 200801408 A EA200801408 A EA 200801408A EA 200801408 A EA200801408 A EA 200801408A EA 200801408 A1 EA200801408 A1 EA 200801408A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- gastrointestinal tract
- methods
- disorders
- diseases
- treatment
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 201000006549 dyspepsia Diseases 0.000 abstract 4
- 208000035475 disorder Diseases 0.000 abstract 3
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 1
- 206010009900 Colitis ulcerative Diseases 0.000 abstract 1
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 206010021518 Impaired gastric emptying Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
- ZOOGRGPOEVQQDX-UHFFFAOYSA-N cyclic GMP Natural products O1C2COP(O)(=O)OC2C(O)C1N1C=NC2=C1NC(N)=NC2=O ZOOGRGPOEVQQDX-UHFFFAOYSA-N 0.000 abstract 1
- 208000001288 gastroparesis Diseases 0.000 abstract 1
- 208000024798 heartburn Diseases 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73949105P | 2005-11-23 | 2005-11-23 | |
| PCT/US2006/045289 WO2007062168A2 (en) | 2005-11-23 | 2006-11-22 | Methods and compositions for the treatment of gastrointestinal disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200801408A1 true EA200801408A1 (ru) | 2008-12-30 |
Family
ID=38067930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200801408A EA200801408A1 (ru) | 2005-11-23 | 2006-11-22 | Способы и композиции, применяемые при лечении расстройств желудочно-кишечного тракта |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20090233882A1 (https=) |
| EP (1) | EP1957509A4 (https=) |
| JP (1) | JP2009517391A (https=) |
| KR (1) | KR20080071193A (https=) |
| CN (2) | CN101360756A (https=) |
| AU (1) | AU2006318429A1 (https=) |
| BR (1) | BRPI0618859A2 (https=) |
| CA (1) | CA2630241A1 (https=) |
| EA (1) | EA200801408A1 (https=) |
| IL (1) | IL191537A0 (https=) |
| MX (1) | MX2008006550A (https=) |
| NO (1) | NO20082758L (https=) |
| NZ (1) | NZ568400A (https=) |
| WO (1) | WO2007062168A2 (https=) |
| ZA (1) | ZA200804500B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10543207B2 (en) * | 2008-12-31 | 2020-01-28 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| WO2012099350A2 (ko) * | 2011-01-18 | 2012-07-26 | 한국기계연구원 | 상온진공과립분사 공정을 위한 취성재료 과립 및 이를 이용한 코팅층의 형성방법 |
| KR101380836B1 (ko) * | 2011-01-18 | 2014-04-09 | 한국기계연구원 | 상온진공과립분사 공정을 위한 취성재료 과립 및 이를 이용한 코팅층의 형성방법 |
| EP2934495B1 (en) * | 2012-12-21 | 2017-07-19 | National Health Research Institutes | Mesoporous silica nanoparticles for oil absorption |
| US12544389B2 (en) | 2014-05-29 | 2026-02-10 | Fresh Cut Development, Llc | Stable cannabinoid formulations |
| US11331279B2 (en) | 2014-05-29 | 2022-05-17 | Radius Pharmaceuticals, Inc. | Stable cannabinoid formulations |
| US11911361B2 (en) | 2014-05-29 | 2024-02-27 | Radius Pharmaceuticals, Inc. | Stable cannabinoid formulations |
| JP7113409B2 (ja) | 2016-07-11 | 2022-08-05 | グレイバグ ヴィジョン インコーポレイテッド | ３’，５’－環状グアノシン一リン酸の新規エクアトリアル修飾ポリマー連結マルチマー |
| CA3062814C (en) * | 2017-04-27 | 2023-11-14 | Insys Development Company, Inc. | Stable cannabinoid formulations |
| KR102049881B1 (ko) * | 2018-07-16 | 2019-11-28 | 충북대학교 산학협력단 | 파인애플박 및 페퍼민트 에센셜 오일을 유효성분으로 포함하는 돼지의 위궤양 개선 또는 예방용 사료첨가제 조성물 |
| CN111803484B (zh) * | 2020-09-04 | 2021-08-17 | 郑州大学 | 奥替溴铵在制备抗肿瘤药物中的应用 |
| KR102563307B1 (ko) * | 2020-11-27 | 2023-08-03 | 한국생명공학연구원 | dcGMP를 유효성분으로 포함하는 면역 증강용 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2007350A6 (es) * | 1987-05-29 | 1989-06-16 | Ganadera Union Ind Agro | Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion. |
| JPH11505258A (ja) * | 1995-05-17 | 1999-05-18 | セダーシナイ メディカル センター | 小腸における消化および吸収を改善させる脂肪酸を含む組成物 |
| US20040192638A1 (en) * | 2001-07-02 | 2004-09-30 | Oaks John A. | Method and composition for prolonging the residence time of drugs in the gut |
| US7304036B2 (en) * | 2003-01-28 | 2007-12-04 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US20080025966A1 (en) * | 2004-01-30 | 2008-01-31 | Currie Mark G | Methods And Compositions For The Treatment Of Gastrointestinal disorders |
-
2006
- 2006-11-22 EP EP06838316A patent/EP1957509A4/en not_active Withdrawn
- 2006-11-22 MX MX2008006550A patent/MX2008006550A/es not_active Application Discontinuation
- 2006-11-22 US US12/094,794 patent/US20090233882A1/en not_active Abandoned
- 2006-11-22 WO PCT/US2006/045289 patent/WO2007062168A2/en not_active Ceased
- 2006-11-22 KR KR1020087015231A patent/KR20080071193A/ko not_active Ceased
- 2006-11-22 CA CA002630241A patent/CA2630241A1/en not_active Abandoned
- 2006-11-22 EA EA200801408A patent/EA200801408A1/ru unknown
- 2006-11-22 CN CNA2006800516447A patent/CN101360756A/zh active Pending
- 2006-11-22 BR BRPI0618859-1A patent/BRPI0618859A2/pt not_active IP Right Cessation
- 2006-11-22 AU AU2006318429A patent/AU2006318429A1/en not_active Abandoned
- 2006-11-22 ZA ZA200804500A patent/ZA200804500B/xx unknown
- 2006-11-22 NZ NZ568400A patent/NZ568400A/en not_active IP Right Cessation
- 2006-11-22 CN CN2011102043900A patent/CN102342953A/zh active Pending
- 2006-11-22 JP JP2008542452A patent/JP2009517391A/ja active Pending
-
2008
- 2008-05-19 IL IL191537A patent/IL191537A0/en unknown
- 2008-06-18 NO NO20082758A patent/NO20082758L/no not_active Application Discontinuation
-
2011
- 2011-07-01 US US13/175,127 patent/US20120172325A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1957509A4 (en) | 2010-10-27 |
| CN102342953A (zh) | 2012-02-08 |
| US20090233882A1 (en) | 2009-09-17 |
| NO20082758L (https=) | 2008-08-22 |
| IL191537A0 (en) | 2008-12-29 |
| WO2007062168A2 (en) | 2007-05-31 |
| KR20080071193A (ko) | 2008-08-01 |
| AU2006318429A1 (en) | 2007-05-31 |
| MX2008006550A (es) | 2008-09-23 |
| US20120172325A1 (en) | 2012-07-05 |
| CA2630241A1 (en) | 2007-05-31 |
| WO2007062168A3 (en) | 2007-12-06 |
| JP2009517391A (ja) | 2009-04-30 |
| ZA200804500B (en) | 2009-08-26 |
| BRPI0618859A2 (pt) | 2011-09-13 |
| EP1957509A2 (en) | 2008-08-20 |
| NZ568400A (en) | 2011-11-25 |
| CN101360756A (zh) | 2009-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082758L (https=) | ||
| NO20053864L (no) | Fremgangsmater og blandinger for behandling av gastrointestinale forstyrrelser. | |
| CY1112321T1 (el) | Ενωσεις βενζιμιδαζολονης οι οποιες εχουν αγωνιστικη δραστικοτητα υποδοχεων 5-ητ4 | |
| BRPI0508558A (pt) | métodos e composições para o tratamento de disturbios gastrintestinais | |
| WO2007022531A3 (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
| NO20083562L (no) | Cannabinoidreseptormodulatorer | |
| DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
| EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
| WO2008059370A3 (en) | Substituted bicyclocarboxyamide compounds | |
| WO2005072113A3 (en) | Compositions and methods of treatment for inflammatory diseases | |
| EA201170714A1 (ru) | Модуляторы tgr5 и способы их применения | |
| WO2006086653A3 (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
| ATE520651T1 (de) | Substituierte phenylmethylbicyclocarbonsäureamidverbindungen | |
| ATE512969T1 (de) | Benzimidazolderivate als selektive säurepumpenhemmer | |
| EA200802360A1 (ru) | Композиция и способ для связывания ацетальдегида в желудке | |
| WO2011103311A3 (en) | Treatments for gastrointestinal disorders | |
| NO20082747L (no) | Arylisoksazol-4-yl-imidazolderivater | |
| WO2011071927A3 (en) | Treatments for gastrointestinal disorders | |
| NO20092092L (no) | Arylsulfamidderivater og fremgangsmater for anvendelse derav | |
| NO20091058L (no) | Sulfonamidforbindelse eller salt derav | |
| WO2005074575A3 (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
| WO2006102069A3 (en) | Methods and compositions for the treatment of hypertension and gastrointestinal disorders | |
| NO20052998D0 (no) | Alfa krystallinsk form av strontiumranelat, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den. | |
| ATE442140T1 (de) | Chroman-substituierte benzimidazolderivate als säurepumpenantagonisten | |
| WO2007019888A3 (en) | Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases |